Twelve patients with growth hormone-producing pituitary adenomas were investigated to evaluate cor relations between magnetic resonance (MR) appearance and tissue characteristics, sellar expansion, suprasellar tumor extension, and tumor consistency. MR imaging could detect microadenomas with a characteristic enhancement delay of gadolinium-diethylenetriaminepenta-acetic acid in the surround ing normal pituitary gland. Macroadenomas and giant tumors appeared on T<SUB>2</SUB>-weighted images as mostly high intensity, while varied greatly on T<SUB>1</SUB>-weighted images. The signal intensities of growth hormone-producing adenomas were more homogeneous (80%) than those of other functioning and non-functioning adenomas on T<SUB>1</SUB>-weighted images. However, there was no typical MR imaging for the tissue characteristics of the growth hormone-producing adenomas, and no particular correlation with suprasellar extension or consistency. Postoperative MR findings showed that the transcranial approach was superior for total or subtotal removal of large tumors, especially with suprasellar ex tension up to the upper third ventricle. The transsphenoidal approach can achieve a satisfactory decompressive effect on the optic chiasm, but more radical removal is required to achieve a normal hormone level.
Introduction
Pituitary adenomas of different types are difficult to differentiate preoperatively.
The magnetic resonance (MR) appearance does not depend on the hormones secreted, and therefore different functioning adenomas look identical. Accurate preoperative localization, especially of suprasellar extension and invasion, are very important for selecting the ap propriate surgical approach for total or maximum removal.
We The T, and T2-weighted MR images were analyzed on the basis of tissue characteristics, suprasellar tumor extension, and tumor consistency. Surgical outcomes were analyzed based on tumor extension, surgical approaches, postoperative growth hormone levels, and changes in the visual fields. MR signal in tensities of growth hormone-producing adenomas were compared with those of other functioning and non-functioning adenomas.
Results
The sellar size was normal in two cases, expanded in eight, and expanded and eroded in two. In females, the adenomas were relatively smaller and did not ex tend to the third ventricle (Table 1) , possibly due to early diagnosis. There was no invasion to the cavernous sinus.
The basal levels of growth hormone varied greatly, especially in males (14-684.1 ng/ml), although in most females it was within 5-25 ng/ml and in only one patient 235.2 ng/ml.
The MR signal intensity of growth hormone-pro ducing adenoma varied greatly on the T,-weighted images. On the T2-weighted images, most gave high intensities irrespective of tumor extension. There was no definite variation in signal intensity with tumor ex tension ( Table 2) . Comparison of T,-weighted MR images with those of other functioning and non-func tioning adenomas') revealed that heterogeneity was less in growth hormone-producing adenomas (Table  3) . Microadenomas appeared as low intensity on T, weighted MR images, with greater enhancement of the host pituitary glands than the adenomas using adolinium-diethylenetriaminepenta-acetic acid (Gd DTPA) (Fig. 1) . right: MR image immediately after Gd-DTPA enhancement, demonstrating host pituitary gland with infundibulum more enhanced than the adenoma. Table 1 Tumor  extension  and sex   Table 2 MR signal intensity and tumor extension Table 3 Type of adenoma and MR findings Table 4 shows no correlation between tumor con sistency and MR signal intensity. Comparison with non-functioning adenomas showed that gelatinous consistency was less frequent in non-functioning tumors, but growth hormone-producing adenomas did not include intratumoral hemorrhage. There was no correlation between tumor consistency and tumor extension (Table 5) .
Adenoma was removed by the transsphenoidal ap proach in eight cases, transcranial in one, and staged operation in three (Table  6 ). The one-stage transsphenoidal approach achieved total removal in only four cases. The transcranial approach was used only for the tumors with extension up to the third ventricle, with better results.
The period of clinical manifestations of acromega ly ranged from 1 to 60 years. Only three patients had visual field defects, which improved postoperatively. In all cases, growth hormone levels decreased after the operation, as shown in Table 7 . Table 4 MR signal intensity and tumor consistency Table 5 Tumor consistency and tumor extension Gd-DTPA, adenomas are not initially perfused to the same degree as the normal host gland.') Adenomas are enhanced more slowly and persis tently than the host pituitary.2) Therefore, immedi ately post-injection, the adenoma appears hypoin tense compared to the normal gland tissue.') MR imaging is very efficient for the identification of microadenomas.') However, functioning adenomas appear identical on MR images.',') In our series of 12 growth hormone-producing adenomas, T2-weighted images demonstrated mostly (80%) high intensity, while T,-weighted images and no definite correlation with size, tumor extension, or tumor consistency. MR images of growth hormone-producing adenomas and other functioning and non-functioning adenomas were not similar, but there were no characteristic differences. One striking result was that signal intensities of growth hormone-producing adenomas were more homogeneous (80%) than that of other adenomas.
Acromegaly is usually clinically obvious and can be readily confirmed by evaluation of growth hor mone secretion. Basal levels were greater than 10 ng/ ml in nine of 11 patients in this series, and in all cases typical acromegalic features were present. This endocrinological potential did not always cor relate with the tumor size disclosed by MR im aging. The two main goals for surgical removal of growth hormone-producing adenomas are to nor malize the hormonal level and to decompress the visual tract. In most cases, decompression can be achieved by partial removal of adenomas, but clin ical recovery from acromegaly requires normal growth hormone levels, necessitating total removal. MR imaging reveals that in many cases of suprasel lar adenomas total removal is not possible by one stage transsphenoidal operation. In our series, most patients were operated on by the transsphenoidal approach and total removal was possible in 50% of cases. The one-stage transcranial approach was used for tumors extending to the third ventricle, achieving one total and one subtotal removal. Since the success rate by the transsphenoi dal approach was not so good, we recommend that either the one-stage transcranial approach or staged transsphenoidal route should be applied.
